Carew Claire, Rak Ashleigh, Tuckerman Jane, Pidd Deborah, Vasiliadis Sophie, Danchin Margie, Kaufman Jessica
Vaccine Uptake Group, Murdoch Children's Research Institute, 50 Flemington Road, Parkville VIC 3052 Australia; Melbourne School of Population and Global Health, The University of Melbourne, 207 Bouverie Street, Carlton VIC 3053 Australia.
Vaccine Uptake Group, Murdoch Children's Research Institute, 50 Flemington Road, Parkville VIC 3052 Australia.
Midwifery. 2025 Jul;146:104402. doi: 10.1016/j.midw.2025.104402. Epub 2025 Apr 7.
New maternal vaccine introduction may affect pregnant women's information needs and decision-making processes.
The number of vaccines available to pregnant women in Australia has doubled with the introduction of the COVID-19 vaccine during the pandemic and recent approval of respiratory syncytial virus (RSV) vaccine.
This study explored the maternal vaccine experiences and evolving information needs of Australian pregnant women during and since the pandemic.
This qualitative study recruited participants through social media and a Melbourne public antenatal clinic. Eligible women were either pregnant mid-pandemic (gave birth May 2021-April 2022) or pregnant post-pandemic during the study period (June 2023-March 2024). Online interviews exploring information-seeking and decision-making practices for influenza, pertussis, COVID-19, and maternal RSV vaccines were inductively thematically analysed.
We interviewed twenty-two women with different levels of vaccine acceptance, identifying four themes: (i) "Full mother mode" to protect the baby - perceived disease risk influenced vaccine decision-making; (ii) "Fear of the unknown and comfort of the familiar" - testing and safety data on known vaccines provided confidence. More information was needed for the new RSV vaccine due to less familiarity; (iii) Whatever the provider says, "she's the professional" - providers' recommendations and personal vaccine decisions provided reassurance; (iv) "I want time to learn about it" - women preferred consistent information early in pregnancy for unhurried decision-making.
Information about new maternal vaccines like RSV should be provided early in pregnancy, emphasising vaccine testing rigour, effectiveness and safety for the baby. Consistent recommendations across providers are essential.
新型孕产妇疫苗的引入可能会影响孕妇的信息需求和决策过程。
在大流行期间引入新冠疫苗以及近期呼吸道合胞病毒（RSV）疫苗获批后，澳大利亚可供孕妇使用的疫苗数量增加了一倍。
本研究探讨了大流行期间及之后澳大利亚孕妇的孕产妇疫苗接种经历和不断变化的信息需求。
这项定性研究通过社交媒体和墨尔本一家公共产前诊所招募参与者。符合条件的女性要么是在大流行中期怀孕（2021年5月至2022年4月分娩），要么是在研究期间（2023年6月至2024年3月）大流行之后怀孕。对有关流感、百日咳、新冠和孕产妇RSV疫苗的信息寻求和决策做法进行的在线访谈进行了归纳主题分析。
我们采访了22名对疫苗接受程度不同的女性，确定了四个主题：（i）“全力母亲模式”以保护婴儿——感知到的疾病风险影响疫苗决策；（ii）“对未知的恐惧和对熟悉事物的安心”——已知疫苗的检测和安全数据提供了信心。由于对新型RSV疫苗不太熟悉，因此需要更多信息；（iii）无论提供者怎么说，“她是专业人士”——提供者的建议和个人疫苗决策让人安心；（iv）“我想有时间了解一下”——女性希望在怀孕早期获得一致的信息，以便从容做出决策。
应在怀孕早期提供有关新型孕产妇疫苗（如RSV疫苗）的信息，强调疫苗检测的严格性、对婴儿的有效性和安全性。各提供者给出一致的建议至关重要。
